Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
RayzeBio, Inc. (RYZB)
NASDAQ:RYZB
Holding RYZB?
Track your performance easily
RYZB Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$17.95 - $62.51
Previous Close$62.49
Volume282.72K
Average Volume (3M)819.20K
Market Cap
$3.81B
Enterprise Value$3.28B
Total Cash (Recent Filing)$540.17M
Total Debt (Recent Filing)$9.72M
Price to Earnings (P/E)―
Beta2.51
Next Earnings
Nov 13, 2023EPS Estimate
-$0.69Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding59,826,184
10 Day Avg. Volume107,461
30 Day Avg. Volume819,202
Standard Deviation0.72
R-Squared0.08
Alpha0.17
Financial Highlights & Ratios
Price to Book (P/B)6.50
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)-16.40
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit10.00T>
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
$62.50Price Target Upside0.02% Upside
Rating ConsensusHold
Number of Analyst Covering3
RayzeBio, Inc. News
PremiumCompany Announcements
RayzeBio, Inc. Completes Merger and Delists from Nasdaq
Ownership Overview
14.05% Insiders
8.92% Mutual Funds
73.97% Other Institutional Investors
3.06% Public Companies and
Individual Investors
RYZB FAQ
What was RayzeBio, Inc.’s price range in the past 12 months?
RayzeBio, Inc. lowest stock price was $17.95 and its highest was $62.51 in the past 12 months.
What is RayzeBio, Inc.’s market cap?
Currently, no data Available
When is RayzeBio, Inc.’s upcoming earnings report date?
RayzeBio, Inc.’s upcoming earnings report date is Nov 13, 2023 which is 375 days ago.
How were RayzeBio, Inc.’s earnings last quarter?
Currently, no data Available
Is RayzeBio, Inc. overvalued?
According to Wall Street analysts RayzeBio, Inc.’s price is currently Undervalued.
Does RayzeBio, Inc. pay dividends?
RayzeBio, Inc. does not currently pay dividends.
What is RayzeBio, Inc.’s EPS estimate?
RayzeBio, Inc.’s EPS estimate is -$0.69.
How many shares outstanding does RayzeBio, Inc. have?
RayzeBio, Inc. has 61,034,000 shares outstanding.
What happened to RayzeBio, Inc.’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of RayzeBio, Inc.?
Among the largest hedge funds holding RayzeBio, Inc.’s share is Viking Global Investors LP. It holds RayzeBio, Inc.’s shares valued at 413M.
---
RayzeBio, Inc. Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Hold
Average Price Target:
$62.50 (0.02% Upside)
$62.50 (0.02% Upside)
Blogger Sentiment
Bullish
RYZB Sentiment 100%
Sector Average 70%
Sector Average 70%
Hedge Fund Trend
Increased
By 90.5K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Bought Shares
Worth $100.0K over
the Last 3 Months
the Last 3 Months
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Company Description
RayzeBio, Inc.
RayzeBio, Inc. develops radiopharmaceutical therapeutics (RPT) for the treatment of cancer. The company's lead drug candidate is RYZ101, which is in phase 3 clinical trial for the treatment of gasteroenteropancreatic neuroendocrine tumors (GEP-NETs). It also develops RYZ801, a novel proprietary peptide that targets GPC3 for delivery of Ac225 for the treatment of hepatocellular carcinoma (HCC); RYZ811, a paired diagnostic imaging agent with the peptide binder, chelator, and Ga68 as the radioisotope; and a novel proprietary small molecule that targets CA9 for delivery of Ac225 for the treatment of ccRCC. The company was incorporated in 2020 and is based in San Diego, California.
---
RYZB Stock 12 Month Forecast
Average Price Target
$62.50
▲(0.02% Upside)
Technical Analysis
Ultragenyx Pharmaceutical
―
Rocket Pharmaceuticals
―
RegenXBio
―
Rhythm Pharmaceuticals
―
Best Analysts Covering RYZB
1 Year
1 Year Success Rate
1/1 ratings generated profit
1 Year Average Return
+212.40%
initiated a buy rating a year ago
Copying Michael Yee's trades and holding each position for 1 Year would result in 100.00% of your transactions generating a profit, with an average return of +212.40% per trade.
---